The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 73,403 | 4,080,237 | SH | SOLE | 4,080,237 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | COM | 56854Q101 | 18,389 | 1,431,059 | SH | SOLE | 1,431,059 | 0 | 0 | ||
| REPLIMUNE GROUP INC | COM | 76029N106 | 48,858 | 2,122,415 | SH | SOLE | 2,122,415 | 0 | 0 | ||
| SOLID BIOSCIENCES INC | COM | 83422E105 | 7,858 | 3,871,164 | SH | SOLE | 3,871,164 | 0 | 0 | ||
| APTINYX INC | COM | 03836N103 | 18,787 | 5,558,425 | SH | SOLE | 5,558,425 | 0 | 0 | ||
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 347,100 | 7,281,307 | SH | SOLE | 7,281,307 | 0 | 0 | ||
| DYNAVAX TECHNOLOGIES CORP. | COM | 268158201 | 47,070 | 10,895,773 | SH | SOLE | 10,895,773 | 0 | 0 | ||
| CONSTELLATION PHARMACEUTICALS INC. | COM | 210373106 | 28,364 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
| X4 PHARMACEUTICALS INC | COM | 98420X103 | 11,160 | 1,648,485 | SH | SOLE | 1,648,485 | 0 | 0 | ||
| SAVARA INC | COM | 805111101 | 22,976 | 5,128,593 | SH | SOLE | 5,128,593 | 0 | 0 | ||
| ARCUTIS BIOTHERAPEUTICS, INC. | COM | 03969K108 | 116,593 | 3,979,292 | SH | SOLE | 3,979,292 | 0 | 0 | ||
| MERSANA THERAPEUTICS, INC. | COM | 59045L106 | 64,158 | 3,445,667 | SH | SOLE | 3,445,667 | 0 | 0 | ||
| CRINETICS PHARMACEUTICALS, INC. | COM | 22663K107 | 16,789 | 1,071,428 | SH | SOLE | 1,071,428 | 0 | 0 | ||
| SAGE THERAPEUTICS, INC. | COM | 78667J108 | 30,505 | 499,100 | SH | SOLE | 499,100 | 0 | 0 | ||
| AEGLEA BIOTHERAPEUTICS, INC. | COM | 00773J103 | 19,143 | 2,700,000 | SH | SOLE | 2,700,000 | 0 | 0 | ||
| ANNEXON INC | COM | 03589W102 | 97,994 | 3,241,628 | SH | SOLE | 3,241,628 | 0 | 0 | ||
| NURIX THERAPEUTICS, INC. | COM | 67080M103 | 44,835 | 1,284,314 | SH | SOLE | 1,284,314 | 0 | 0 | ||
| KYMERA THERAPEUTICS INC. | COM | 501575104 | 23,574 | 729,606 | SH | SOLE | 729,606 | 0 | 0 | ||
| PANACEA ACQUISITION CORP | UNIT 99/99/9999 | 698102209 | 5,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| THERAPEUTICS ACQUISITION COR | COM CL A | 88339T103 | 14,380 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| ARYA SCIENCES ACQUISITION CORP III | COM CL A | G3166W106 | 10,815 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| BCTG ACQUISITION CORP | COM | 05492W103 | 5,180 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||